Skip navigation
logo
(AFX UK Focus) 2008-11-19 13:20
BRIEF-Perrigo acknowledges settlement of Nasacort patent litigation
Article layout: raw

Nov 19 (Reuters) - Perrigo Co:

  • PERRIGO ACKNOWLEDGES SETTLEMENT OF NASACORT AQ NASAL SPRAY PATENT LITIGATION

  • SAYS UNDER THE SETTLEMENT BARR WILL BE ABLE TO MARKET ANDA PRODUCT UNDER
    license from Sanofi Aventis-as early as June 15, 2011

  • SAYS BARR WILL HAVE A LICENSE TO LAUNCH A GENERIC VERSION OF NASACORT AQ,
    supplied by Sanofi Aventis

  • SAYS IT WILL SHARE IN COSTS AND BENEFITS OF SETTLEMENT AGREEMENT BETWEEN BARR
    and Sanofi Aventis

    ((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here)

    COPYRIGHT

    Copyright Thomson Reuters 2008. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

  • Re-organisations, re-structurings, name changes, AGM, EGM
    Article layout: raw
    Jump back to site navigation